Author Correction | Published:

Author Correction: Inflammasome signalling in brain function and neurodegenerative disease

Nature Reviews Neurosciencevolume 20page187 (2019) | Download Citation

Subjects

Nature Reviews Neuroscience (2018) https://doi.org/10.1038/s41583-018-0055-7 Published online 11 September 2018

In the originally published version of this article, the competing interests statement indicated that the authors had no competing interests; however, this statement was incorrect. The statement should have read as follows: ‘M.H. receives a consultation fee from IFM Therapeutics, LLC for consultations regarding the pathogenesis and interventional strategies of neurodegenerative disease. E.L. is a scientific co-founder and consultant to IFM Therapeutics. R.M.M. declares no competing interests.’ This error has been corrected in the HTML and PDF versions of the article.

Author information

Affiliations

  1. Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Bonn, Germany

    • Michael T. Heneka
    •  & Róisín M. McManus
  2. German Center for Neurodegenerative Diseases, Bonn, Germany

    • Michael T. Heneka
    • , Róisín M. McManus
    •  & Eicke Latz
  3. Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA

    • Michael T. Heneka
    •  & Eicke Latz
  4. Institute of Innate Immunity, University of Bonn, Bonn, Germany

    • Eicke Latz

Authors

  1. Search for Michael T. Heneka in:

  2. Search for Róisín M. McManus in:

  3. Search for Eicke Latz in:

Corresponding author

Correspondence to Michael T. Heneka.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/s41583-019-0137-1